MedRhythms today announced that CMS established a new HCPCS code to describe InTandem: E3200 (gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only). CMS also determined that InTandem qualified under Medicare’s durable medical equipment (DME) benefit category based on InTandem’s durability and indication for home use. Learn more in the press release:
MedRhythms, Inc.
生物技术研究
Portland，Maine 6,905 位关注者
Creating a world where everyone with neurologic injuries and diseases has access to the highest quality care.
关于我们
MedRhythms is developing next-generation neurotherapeutics that leverage the power of music and technology to redefine what's possible in brain health, for patients around the world. Our devices are designed to improve walking, mobility and related functional outcomes via a proprietary, patented technology platform. This platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. We are developing a pipeline of digital therapeutics across a range of neurological conditions, including stroke, multiple sclerosis and Parkinson’s disease. For more information about how we are pioneering digital therapeutics, visit https://medrhythms.com/
- 网站
-
https://www.medrhythms.com
MedRhythms, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Portland，Maine
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Neurologic Music Therapy、Neuroscience、Innovation、Digital Medicine、Sensors、Data Analytics 、Medical Device和Software
地点
-
主要
获取路线
183 Middle St
US，Maine，Portland，04101
MedRhythms, Inc.员工
动态
-
We invite you to join us for a free introduction to NMT and MedRhythms Therapy's student programs! Click the link to reserve your spot:
Welcome! You are invited to join a meeting: Intro to NMT & MedRhythms Therapy. After registering, you will receive a confirmation email about joining the meeting.
-
The MedRhythms team is excited to be at the North American Brain Injury Society (NABIS) in Las Vegas this week! Join Brian Harris, CEO and Co-Founder of MedRhythms, on Friday, March 29th at 5:30 pm for his presentation entitled "The Cutting-Edge Neuroscience of Music: Clinical Applications for Brain Injury". Attending NABIS and want to connect? Email: [email protected]
-
-
MedRhythms is hiring! Check out our open positions on our website *Note that we do not contact you via text or conduct messaging interviews via Microsoft Teams. Please be vigilant to avoid scams!
Careers | MedRhythms
https://medrhythms.com
-
MedRhythms is hiring! Check out our open positions on our website *Note that we do not contact you via text or conduct messaging interviews via Microsoft Teams. Please be vigilant to avoid scams!
Careers | MedRhythms
https://medrhythms.com
-
“Stroke can significantly impact a person’s ability to walk, putting them at greater risk for falls, other health conditions and poorer quality of life,” said Paolo Bonato, PhD, director of the Motion Analysis Lab at Spaulding Rehabilitation. “Our trial shows that an intervention applying algorithmically-controlled music as a rhythmic stimulus improves walking and ambulation by inciting and harnessing the unconscious synchronization of the auditory and motor systems.” Read the study published in Nature Communications to learn more: https://buff.ly/49uy9ir
-
-
Meet with MedRhythms at the APTA Combined Sections Meeting this week in Boston! Feb 15 @ 3pm: NE-18570 New Frontiers in Neurorehabilitation: Applying the Neuroscience of Music to Treat Neurological Conditions. Feb 16 @ 5:30pm ET – Register in Advance: The Science of InTandem. Plus: Come by the InTandem booth #11086 to learn more & demo the platform https://buff.ly/49xeBKC
-
-
The MedRhythms Therapy team is growing! We have lots of new job openings that are posted on our website and are looking for people who want to work at a fast-paced, mission-driven startup. Don’t see an open role that is the right fit for you? Check out our General Interest posting! Our team is growing quickly, we may have a role opening that fits your background in the near future. Learn more and apply today with the following link: https://buff.ly/3HVmhKC
-